Cipro and Ifosfamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Ifosfamide (ifosfamide). Common drug interactions include anaemia among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Cipro and Ifosfamide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.



On Jul, 16, 2026

17 people who take Cipro and Ifosfamide together, and have interactions are studied.

Cipro and Ifosfamide drug interactions.

What are the common drug interactions of Cipro and Ifosfamide, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Ewing's sarcoma (malignant small, round, blue cell tumour)
  3. Peripheral swelling
  4. Abdominal pain
  5. Asthenia (weakness)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Cystitis haemorrhagic (blood in the urine and painful voiding)
  8. Diarrhoea
  9. Drug toxicity
  10. Febrile neutropenia (fever with reduced white blood cells)

male:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Viith nerve paralysis
  4. Alanine aminotransferase increased
  5. Anaemia (lack of blood)
  6. Aspartate aminotransferase increased
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Diarrhoea
  9. Fatigue (feeling of tiredness)
  10. Gallbladder enlargement

What are the common drug interactions of Cipro and Ifosfamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Mucosal inflammation (infection of mucous membrane)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Skin lesion

30-39:

n/a

40-49:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Lung infection
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Alanine aminotransferase increased
  7. Anaemia (lack of blood)
  8. Aspartate aminotransferase increased
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Gallbladder enlargement

50-59:

  1. Anaemia (lack of blood)
  2. Ewing's sarcoma (malignant small, round, blue cell tumour)
  3. Peripheral swelling
  4. Asthenia (weakness)
  5. International normalised ratio increased
  6. Neutropenia (an abnormally low number of neutrophils)

60+:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  3. Weakness
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Hepatomegaly (abnormal enlargement of the liver)
  7. Hypokalaemia (low potassium)
  8. Hypotension (abnormally low blood pressure)
  9. Insomnia (sleeplessness)
  10. Neutropenia (an abnormally low number of neutrophils)

What are the existing conditions these people have? *

  1. Back Pain: 4 people, 23.53%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 23.53%
  3. Vena Cava Thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart): 3 people, 17.65%
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 17.65%
  5. Bipolar Disorder (mood disorder): 3 people, 17.65%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 17.65%
  7. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 17.65%
  8. Cough: 3 people, 17.65%
  9. Diarrhea: 3 people, 17.65%
  10. Drowsiness: 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Ifosfamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cipro and Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ifosfamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride and ifosfamide (the active ingredients of Cipro and Ifosfamide, respectively), and Cipro and Ifosfamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: